Rohan Singh 
Dealstreet

Fox Mandal & Associates assists Samarsh Capital on investment in SAI Parenterals

Samarsh Capital led SAI Parenterals' ₹50 crore fundraise.

Bar & Bench

Fox Mandal & Associates LLP has advised Samarsh Capital on leading the ₹50 crore fundraise of Sai Parenterals Limited.

The transaction team consisted of Rohan Singh (Partner) and Siddhi Kasekar (Associate).

Sai Parenterals

SAI Parenteralis an Indian pharmaceutical company with a proven track record in the formulations segment which operates across the pharmaceutical value chain, including research & development (R&D), manufacturing, regulatory compliance, marketing, and exports.

The Company will utilize the funds for global expansion, enhancement of manufacturing capabilities and diversification of product offering.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Delhi Deputy CM Parvesh Sahib Singh files ₹5 crore defamation suit against AAP's Saurabh Bharadwaj

Karnataka HC grants anticipatory bail to mother of man booked for rape, religious conversion of his wife

Kudankulam Nuclear Plant's safety analysis report exempt from RTI disclosure: Delhi High Court

New projects need not conform to height of older DDA flats in vicinity: Delhi HC clears Vasant Kunj high‑rise

ELP strengthens Leadership Team with promotion of 3 Partners, 8 Senior Leaders

SCROLL FOR NEXT